INVOBENITUG

UNII:	CFF2BLH47W
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	INVOBENITUG
GSRS Full Record:	CFF2BLH47W i

3034173-09-3
AK-1967
AK1967
H-gamma1 heavy chain humanized (1-445) [VH (Homo sapiens IGHV2-5*01 (89.8%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT[10.7.8] (26-35.53-59.98-105)) (1-116) -Homo sapiens IGHG1*01 (100%) G1m17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (213) (117-214), hinge 1-15 (215-229), CH2 (230-339), CH3 D12 (355), L14 (357) (340-444), CHS K2>del (445)) (117-445)], (219-219')-disulfide with L-kappa light chain humanized (1'-219') [V-KAPPA (Homo sapiens IGKV2D-29*02 (91.0%) -IGKJ4*01 (100%), CDR-IMGT [11.3.9] (27'-37'.55'-57'.94'-102')) (1'-112') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (158'), V101 (196')) (113'-219')]; dimer (225-225'':228-228'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-DG44, glycoform alfa
INVOBENITUG [USAN]
Immunoglobulin G1, anti-(human dipeptidyl peptidase III) (human-Mus musculus monoclonal AK1967 γ1-chain), disulfide with human-Mus musculus monoclonal AK1967 κ-chain, dimer
Invobenitug
Procizumab
immunoglobulin G1-kappa, anti-[Homo sapiens DPP3 (dipeptidyl peptidase 3) linear epitope (I)NPETGEQIQ, humanized monoclonal antibody
invobenitug [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

INVOBENITUG

Synonyms and Mappings

Resources